Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Instaflex and Joint Pain in Community Adults

Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Odkaz sa uloží do schránky
PostavenieDokončené
Sponzori
Appalachian State University
Spolupracovníci
Direct Digital

Kľúčové slová

Abstrakt

The primary purpose of this study is to assess the effect of 8-weeks ingestion of the Instaflex Joint Support supplement (Direct Digital, Charlotte, NC) compared to placebo on joint pain, stiffness, and function (questionnaires and 6-min walk test) and blood inflammation biomarkers in adults with self-reported joint pain.

Popis

Allocation: Randomized. Subjects will be randomized to one of two groups: placebo or Instaflex Joint Support. Supplements will be administered in double-blinded fashion.

Intervention Model: Instaflex Joint Support supplement for 8 weeks versus placebo.

Sample Size: N=100, with N=50 per group.

Statistical Procedures: 2 x 2 repeated measures analysis of variance (ANOVA).

Study Duration (per subject): 8 weeks.

Blood sample schedule: Blood draws pre- and post-study.

Monitoring adverse events: Subjects will fill in bi-weekly symptom logs to monitor untoward symptoms. Diagnostic chemistry panels will be measured pre- and post-study.

Rescue medication: Paracetamol (i.e., acetaminophen as found in Tylenol) will be allowed as a rescue medicine for pain during the study as needed. Subjects will record paracetamol usage. Paracetamol can relieve pain in mild arthritis but has no effect on the underlying inflammation, redness, and swelling of the joint.

Lab visit testing sequence (at the Kannapolis YMCA, in the afternoon by appointment.):

1. First visit:

1. Consent form

2. Medical health questionnaire to verify medical history, and lifestyle habits.

3. Symptoms log for previous 2-weeks symptomatology

4. Height, weight, and percent body fat (bioelectrical impedance, Tanita scale)

5. Questionnaires: Western Ontario and McMaster Universities Arthritis Index (WOMAC), Short Form (36) Health Survey (SF-36), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP).

6. Blood sample (followed by a glass of orange juice)

7. 6-minute walk test (at the local YMCA track) (one practice trial, and then repeat for test).

8. Receive supplement organizer tray with 8-weeks supply (and instructions)

2. 8-week study:

a. Subjects will be contacted via email every 2 weeks to monitor compliance and fill in symptom logs.

3. Second lab visit:

1. Same as first lab visit, except for removal of steps "a,b, and h".

Supplements:

Supplements (Instaflex, placebo) will be prepared in colored gel capsules (3 per day, identical looking), and given to the subjects in supplement organizer trays. Subjects will take 3 capsules/day: one capsule each in the morning, at noontime, and in the evening. The placebo capsules will contain magnesium stearate, an inert substance.

Compliance:

Compliance will be monitored with bi-weekly email messages, and by counting unused capsules when subjects return the supplement trays at the end of the 8-week study. If subjects miss one, two, or three days of taking supplements, subjects will be asked to double up usage until back on schedule. Subjects missing more than three days of taking the supplements will be asked to leave the study.

1. Instaflex Joint Support Supplement

A serving size is 3 capsules, and contains the following ingredients:

Glucosamine Sulfate 1500 mg Methylsulfonylmethane 500 mg White Willow Bark Extract (standardized to 15% salicin) 250 mg Ginger Root Concentrate 50 mg Boswella Serrata Extract (Standardized to 65% boswellic acid) 125 mg Turmeric Root Extract 50 mg Cayenne 40m H.U. 50 mg Hyaluronic Acid 4.0 mg Other Ingredients: Rice Flour, Gelatin, Vegetable Magnesium Stearate, Silicon Dioxide

Termíny

Naposledy overené: 09/30/2013
Prvý príspevok: 09/26/2013
Odhadovaná registrácia bola odoslaná: 10/06/2013
Prvý príspevok: 10/07/2013
Posledná aktualizácia bola odoslaná: 10/06/2013
Posledná aktualizácia bola zverejnená: 10/07/2013
Aktuálny dátum začatia štúdie: 03/31/2013
Odhadovaný dátum dokončenia primárneho okruhu: 05/31/2013
Odhadovaný dátum dokončenia štúdie: 05/31/2013

Stav alebo choroba

Joint Pain, Stiffness, Function

Intervencia / liečba

Dietary Supplement: Instaflex

Dietary Supplement: Placebo

Fáza

-

Skupiny zbraní

ArmIntervencia / liečba
Experimental: Instaflex
Instaflex Joint Support supplement (3 capsules per day for 8 weeks)
Dietary Supplement: Instaflex
The Instaflex supplement contained the following ingredients (in 3 capsules): Glucosamine sulfate (1500 mg), methylsulfonylmethane (MSM) (500 mg), white willow bark extract (standardized to 15% salicin) (250 mg), ginger root concentrate (50 mg), boswella serrata extract (standardized to 65% boswellic acid) (125 mg), turmeric root extract (50 mg), cayenne 40m H.U. (50 mg), and hyaluronic acid (4.0 mg).
Placebo Comparator: Placebo
Placebo (3 capsules per day for 8 weeks)
Dietary Supplement: Placebo
The placebo capsules will contain magnesium stearate, an inert substance.

Kritériá oprávnenosti

Vek vhodný na štúdium 50 Years To 50 Years
Pohlavia vhodné na štúdiumAll
Prijíma zdravých dobrovoľníkovÁno
Kritériá

Inclusion Criteria:

- Male or female

- ages 50-75 years

- history (>3 months) joint pain, knees, hip, ankles, shoulders, or hands

- willingness to avoid NSAIDs use during the 8-week study

- willingness to avoid other anti-inflammatory medications

- agree to stay weight stable during the 8-week study

- willing to follow all study procedures, including randomization to one of two groups

- able to walk for at least 6 min at a moderate-to-brisk pace

Exclusion Criteria:

- history of regular NSAID use during the previous two weeks

- use of other medications (e.g., analgesic gels, arthritis medications, other anti-inflammatory drugs) or supplements (in particular, glucosamine and chondroitin) for joint pain for the previous two weeks

- serious medical problems (current cancer case, severe rheumatoid arthritis, recent heart attack, recent stroke, congestive heart failure, ulcers, kidney disease, or other disease that will interfere with study participation).

- psychiatric disorder or other condition that might interfere with self-assessment ability.

- history of allergic reactions to shellfish products.

- history of allergic reactions to products containing aspirin.

Výsledok

Primárne výstupné opatrenia

1. Joint pain and function [Change in joint pain and function at 8 weeks]

Assessed through questionnaires

Opatrenia sekundárnych výsledkov

1. Systemic inflammation [Change in systemic inflammation at 8 weeks]

Serum CRP and plasma cytokines (9 total)

2. Safety [Change in safety outcomes at 8 weeks]

Symptoms logs and diagnostic chemistries

Pripojte sa k našej
facebookovej stránke

Najkompletnejšia databáza liečivých bylín podporovaná vedou

  • Pracuje v 55 jazykoch
  • Bylinné lieky podporené vedou
  • Rozpoznávanie bylín podľa obrázka
  • Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
  • Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
  • Vyhľadajte liečivé byliny podľa ich účinkov
  • Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume

Google Play badgeApp Store badge